TETmedical appointed Arjun Ishwar as chief commercial officer to lead commercial strategy for NSE-FAST®, the company’s rapid blood test being developed to aid diagnosis of acute ischemic stroke. Ishwar brings more than 15 years of medical device and diagnostics commercialization experience.
The company says it is advancing NSE-FAST toward a multi-center pivotal study and building commercial infrastructure ahead of a potential market launch. TETmedical previously reported FDA Breakthrough Device Designation for the test. Red Bear Angels looks forward to following the program’s progress.
Read more →
